Sven Guenther - 31 Jan 2024 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Chief Scientific Officer
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Sven Guenther
Issuer symbol
ZVRA
Transactions as of
31 Jan 2024
Net transactions value
$0
Form type
4
Filing time
02 Feb 2024, 20:13:01 UTC
Previous filing
11 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZVRA Restricted Stock Unit Award $0 +79,000 $0.000000 79,000 31 Jan 2024 Common Stock 79,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. Grant to the Reporting Person of restricted stock units ("RSU").
F2 The restricted stock units will vest and settle as to one third of the restricted stock units on January 31, 2025, and the remaining two thirds of the restricted stock units will vest and settle in equal annual installment thereafter, subject in each case to the Reporting person's ongoing employment.